title: Long-term reduction in aortic stiffness: a 5.3-year follow-up in routine clinical practice.
abstract: BACKGROUND
  Whether a direct blood pressure-independent reduction in aortic stiffness can occur after several years of antihypertensive treatment has never been unequivocally demonstrated.
  
  
  METHODS
  In this observational study, performed under conditions of routine clinical practice, we included 97 patients (age 63 ± 11 years) with treated essential hypertension who attended the outpatient hypertension clinic of a university hospital, had a significant blood pressure (BP) lowering under treatment before the first measurement of aortic stiffness, and had at least one additional measurement of aortic stiffness during follow-up. Aortic stiffness and carotid pulse pressure (PP) were determined through carotid-femoral pulse wave velocity (PWV) and applanation tonometry, respectively.
  
  
  RESULTS
  A linear mixed model showed that the reduction in PWV (from 14.2 ± 4.2 to 11.0 ± 2.4 m/s; P < 0.0001) over a long follow-up (mean delay 5.3 ± 1.3 years) was associated with a significant reduction in central SBP (from 132 ± 22 to 122 ± 16 mmHg; P < 0.0001) and central PP (from 59 ± 22 to 54 ± 14; P < 0.001), contrasting with a smaller change in brachial SBP (from 132 ± 17 to 129 ± 16 mmHg; P < 0.02) and no change in brachial PP. In multivariate analysis, the decrease in PWV (-0.70 ± 0.07 m/s per year; P < 0.0001) was only slightly explained by the reduction in mean blood pressure. By contrast, the decrease in central PP (-0.83 ± 0.41 mmHg per year; P = 0.043) was largely explained by the reduction in PWV.
  
  
  CONCLUSIONS
  These results indicate that a large and sustained decrease in aortic stiffness can be obtained in treated hypertensive patients under conditions of routine clinical practice. These changes likely represent a delayed response to the long-term normalization of BP and cardiovascular risk factors, through arterial remodeling.
authors.affiliation: Department of Pharmacology, European Hospital Georges Pompidou, France.
authors.forename: Hafid
authors.initials: H
authors.lastname: Ait-Oufella
authors.forename: Cédric
authors.initials: C
authors.lastname: Collin
authors.forename: Erwan
authors.initials: E
authors.lastname: Bozec
authors.forename: Brigritte
authors.initials: B
authors.lastname: Laloux
authors.forename: Kim-Thanh
authors.initials: KT
authors.lastname: Ong
authors.forename: Carole
authors.initials: C
authors.lastname: Dufouil
authors.forename: Pierre
authors.initials: P
authors.lastname: Boutouyrie
authors.forename: Stéphane
authors.initials: S
authors.lastname: Laurent
mesh_terms: D000368:Aged; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001011:Aorta / Q000187:drug effects / Q000503:physiopathology*; D001794:Blood Pressure / Q000187:drug effects; D002339:Carotid Arteries / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D016014:Linear Models; D008297:Male; D008365:Manometry / Q000379:methods; D008875:Middle Aged; D012044:Regression Analysis; D012307:Risk Factors
chemical_list: D000959:Antihypertensive Agents